Monte Rosa Therapeutics Ownership | Who Owns Monte Rosa Therapeutics?
Monte Rosa Therapeutics Ownership Summary
Monte Rosa Therapeutics is owned by 31.22% institutional investors, 0.71% insiders, and 68.08% retail investors. Nea management company is the largest institutional shareholder, holding 9.38% of GLUE shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 5.54% of its assets in Monte Rosa Therapeutics shares.
GLUE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Monte Rosa Therapeutics | 31.22% | 0.71% | 68.08% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 7.69M | 9.38% | $53.38M |
| Price t rowe associates inc /md/ | 7.12M | 8.68% | $49.39M |
| Versant venture management | 5.65M | 6.89% | $39.23M |
| Fmr | 5.55M | 6.77% | $38.51M |
| Baker bros. advisors lp | 4.92M | 5.99% | $34.12M |
| Avoro capital advisors | 4.34M | 5.30% | $30.15M |
| Blackrock funding, inc. /de | 3.84M | 4.68% | $26.65M |
| Blackrock | 2.36M | 3.92% | $8.83M |
| Vanguard group | 3.16M | 3.85% | $21.91M |
| Bvf inc/il | 2.76M | 3.37% | $19.19M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 5.65M | 45.22% | $39.23M |
| Aisling capital management lp | 1.47M | 3.63% | $10.22M |
| Nea management company | 7.69M | 3.01% | $53.38M |
| Bvf inc/il | 2.76M | 0.65% | $19.19M |
| Alphabet | 1.46M | 0.59% | $10.16M |
| Avoro capital advisors | 4.34M | 0.43% | $30.15M |
| Suvretta capital management | 1.56M | 0.37% | $10.85M |
| Baker bros. advisors lp | 4.92M | 0.36% | $34.12M |
| Ikarian capital | 311.57K | 0.29% | $2.16M |
| Parkwood | 323.00K | 0.25% | $2.24M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Versant venture management | 5.65M | 45.22% | 5.65M |
| Bvf inc/il | 2.76M | 0.65% | 2.76M |
| Blackrock funding, inc. /de | 3.84M | 0.00% | 938.67K |
| Vanguard group | 3.16M | 0.00% | 622.13K |
| Price t rowe associates inc /md/ | 7.12M | 0.01% | 515.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | 4.34M | 0.43% | -1.45M |
| Suvretta capital management | 1.56M | 0.37% | -1.10M |
| Vestal point capital, lp | 425.00K | 0.17% | -505.00K |
| Exoduspoint capital management, lp | - | - | -393.59K |
| Sphera funds management | - | - | -118.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Versant venture management | 5.65M | 45.22% | 5.65M | $39.23M |
| Bvf inc/il | 2.76M | 0.65% | 2.76M | $19.19M |
| Norges bank | 445.87K | 0.00% | 445.87K | $3.09M |
| Quest partners | 94.63K | 0.09% | 94.63K | $656.75K |
| Cubist systematic strategies | 92.82K | 0.00% | 92.82K | $644.16K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Capital performance advisors llp | -29.00 |
| Metropolitan life insurance co/ny | -1.82K |
| Meeder asset management | -10.05K |
| Mirae asset global investments | -11.95K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 55 | -34.52% | 25,603,232 | -48.56% | 31 | 0.85% | 40 | -25.93% | 4 | -66.67% |
| Sep 30, 2024 | 84 | 9.09% | 49,773,785 | 8.59% | 60 | 1.47% | 54 | 14.89% | 12 | - |
| Jun 30, 2024 | 76 | 7.04% | 45,836,354 | 14.90% | 76 | 1.26% | 47 | 62.07% | 12 | -47.83% |
| Mar 31, 2024 | 71 | -10.13% | 39,892,663 | -0.52% | 77 | 1.20% | 29 | 3.57% | 23 | -11.54% |
| Dec 31, 2023 | 79 | 5.33% | 40,102,427 | -4.61% | 80 | 1.11% | 28 | -30.00% | 26 | 52.94% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 3.40M | 5.54% | -2.93K |
| T. Rowe Price New Horizons | 3.40M | 5.53% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.92M | 3.12% | - |
| Fidelity Growth Compy Commingled Pl S | 1.59M | 2.58% | 2.23K |
| HBM Healthcare Investments AG Ord | 1.41M | 2.29% | - |
| iShares Russell 2000 ETF | 1.09M | 1.77% | -9.40K |
| T. Rowe Price Integrated US SmCapGrEq | 1.07M | 1.75% | 536.44K |
| T. Rowe Price Health Sciences | 1.03M | 1.67% | -107.00K |
| Fidelity Growth Company Fund | 976.17K | 1.59% | - |
| Fidelity Growth Compy Commingled Pl O | 970.82K | 1.58% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 24, 2025 | Leo Chandra P. | - | Buy | $58.38K |
| Oct 29, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $146.79K |
| Oct 29, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $475.01K |
| Oct 28, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $869.24K |
| Sep 20, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $7.40M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 1 | - |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | - |
GLUE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools